Atherosclerosis is a disease characterized by the buildup of plaque in arteries. It is caused by a combination of genetic and environmental factors that damage the endothelium and allow lipids and inflammatory cells to accumulate. Over time, plaques grow and can rupture, leading to thrombosis and blockage of blood vessels. This causes cardiovascular diseases like heart attacks and strokes. The major modifiable risk factors are hyperlipidemia, hypertension, smoking, and diabetes.
4. Atherosclerosis underlies the pathogenesis of
coronary, cerebral and peripheral vascular disease
combination of acquired and inherited risk factors
initimal lesions ---- atheromas (atheromatous or
atherosclerotic plaques)
Mechanically obstruction, rupture---- thrombosis
aneurysms.
6. Epidemiology
reduced mortality from infectious , Western
lifestyles --- increased prevalence of ischemic heart
disease in developing nations
number of risk factors
multiplicative effect.
8. Genetics
most important independent risk factor.
Polygenic
Age
dominant influence.
middle age or later------ risk increases five-fold.
Gender
Premenopausal women are relatively protected
compared to age-matched men.
After menopause exceeds that of men
Favorable influence of estrogen
9. Modifiable Major Risk Factors
Hyperlipidemiaspecifically hypercholesterolemia
low-density lipoprotein (LDL) cholesterol
high-density lipoprotein (HDL)
High dietary intake of cholesterol and saturated fats
raises plasma cholesterol levels.
high in polyunsaturated fats lower plasma cholesterol
levels
Omega-3 fatty acids (abundant in fish oils) are
beneficial
Exercise and moderate consumption of ethanol raise
HDL levels whereas obesity and smoking lower it.
Statins --- lower ----inhibiting HMG CoA reductase
10. Hypertension
major risk factor
both systolic and diastolic levels
hypertension increase the risk by approximately
60%
12. Diabetes mellitus
induces hypercholesterolemia
incidence of myocardial infarction is twice
increased risk of stroke
100-fold increased risk of atherosclerosis-induced
gangrene of the lower extremities
13. Additional Risk Factors
20% cases --absence of overt risk factors
Indeed, more than 75% of cardiovascular events in
previously healthy women occur with LDL
cholesterol levels below 160 mg/dL
14. Inflammation
present during all stages of atherogenesis
C-reactive protein (CRP) most sensitive.
CRP is an acute phase reactant synthesized
primarily by the liver.
increased by --- particularly IL-6
15. Hyperhomocystinemia
Correlate with coronary atherosclerosis, peripheral
vascular disease, stroke, and venous thrombosis.
associated with premature vascular disease.
low folate and vitamin B12 levels can increase
homocysteine
16. Metabolic syndrome.
central obesity
characterized by insulin resistance, hypertension,
dyslipidemia, hypercoagulability, and a
proinflammatory state.
17. Lipoprotein a [Lp(a)]
altered form of LDL
Lp(a) levels are associated with coronary and
cerebrovascular disease risk
18. Factors affecting hemostasis.
Several markers of hemostatic and/or fibrinolytic
function (e.g., elevated plasminogen activator
inhibitor 1) ------- risk for major atherosclerotic events
Other factors
lack of exercise;
competitive, stressful life style (type A personality);
Obesity
Hormones
infections
20. Pathogenesis of Atherosclerosis
response to injury hypothesis.
This model views atherosclerosis as a chronic
inflammatory and healing response of the arterial
wall to endothelial injury
Lesion progression occurs through interaction of
modified lipoproteins, monocyte-derived
macrophages, and T lymphocytes with endothelial
cells and smooth muscle cells of the arterial wall.
21. sequence:
Endothelial injury and dysfunction, causing increased
vascular permeability, leukocyte adhesion, and thrombosis
Accumulation of lipoproteins (mainly LDL and its oxidized
forms) in the vessel wall
Monocyte adhesion to the endothelium--- migration into the
intima and transformation into macrophages and foam cells
Platelet adhesion
Factor release from activated platelets, macrophages, and
vascular wall cells, inducing smooth muscle cell recruitment,
either from the media or from circulating precursors
Smooth muscle cell proliferation, extracellular matrix
production, and recruitment of T cells.
Lipid accumulation both extracellularly and within cells
(macrophages and smooth muscle cell)
28. Endothelial Injury
Cornerstone of the response-to-injury hypothesis.
Endothelial loss ---- experimentally by mechanical
denudation, hemodynamic forces, immune
complex deposition, irradiation, or chemicals
results in intimal thickening
intact but dysfunctional endothelial cells exhibit
increased endothelial permeability, enhanced
leukocyte adhesion, and altered gene expression.
However, the two most important
hemodynamic disturbances
hypercholesterolemia.
29. Hemodynamic Disturbances.
Plaques tend to occur at ostia of exiting vessels, branch points,
and along the posterior wall of the abdominal aorta, where
there are disturbed flow patterns
30. Lipids
Lipids are transported in the bloodstream bound to
specific apoproteins (forming lipoprotein complexes)
Dyslipoproteinemias --- increased LDL cholesterol
levels, decreased HDL and increased levels of the
abnormal lipoprotein (a).
31. The mechanisms -----
Chronic hyperlipidemia-------choles. directly impair
endothelial cell function by increasing ROS
causing membrane and mitochondrial damage,
With chronic hyperlipidemia, lipoproteins accumulate
within the intima
Such modified LDL is then accumulated by
macrophages ---- foam cells
lipoproteins binding and uptake also stimulates the
release of growth factors, cytokines, and chemokines-
--- monocyte recruitment and activation
34. Smooth Muscle Proliferation and Matrix Synthesis
convert a fatty streak into a mature atheroma and
contribute to the progressive growth of
atherosclerotic lesions
growth factors PDGF, FGF, TGF-留
synthesize extracellular matrix (notably
collagen),which stabilizes atherosclerotic plaques.
36. MORPHOLOGY
Fatty streaks.
composed of lipid-filled foamy macrophages.
Beginning as multiple minute flat yellow spots, they
eventually coalesce into streaks 1 cm long or longer.
fatty streaks can evolve into plaques, not all are destined to
become advanced lesions.
coronary fatty streaks begin to form in adolescence
Atherosclerotic Plaque
intimal thickening and lipid accumulation, which together
form plaques
white-yellow and encroach on the lumen of the artery;
superimposed thrombus over ulcerated plaques is red-brown.
form larger masses
cross-section, the lesions therefore appear eccentric
with time atherosclerotic lesions can become larger, more
numerous, and more broadly distributed
38. extensively involved vessels
lower abdominal aorta
the coronary arteries
the popliteal arteries
the internal carotid arteries,
vessels of the circle of Willis.
39. Atherosclerotic plaques --- three principal components:
(1) smooth muscle cells, macrophages, and T cells
(2) extracellular matrix, including collagen, elastic fibers, and
proteoglycans
(3) intracellular and extracellular lipid
Typically, there is a superficial fibrous cap composed of smooth
muscle cells and relatively dense collagen.
Beneath and to the side of the cap (the shoulder) is a more
cellular area containing macrophages, T cells, and smooth muscle
cells.
Deep to the fibrous cap is a necrotic core, containing lipid
(primarily cholesterol and cholesterol esters), debris from dead
cells, foam cells (lipidladen macrophages and smooth muscle
cells), fibrin, variably organized thrombus, and other plasma
proteins
periphery of the lesions demonstrate neovascularization
Plaques generally continue to change and progressively enlarge
often undergo calcification
41. CHANGES:
Rupture, ulceration, or erosion --- leads to
thrombosis -- occlude the vessel lumen
Hemorrhage into a plaque. Rupture /thin-walled
vessels in the areas of neovascularization----
hemorrhage---hematoma
Atheroembolism -- discharge microemboli
Aneurysm formation. Atherosclerosis-induced
pressure or ischemic atrophy of the underlying
media.
44. Consequences of Atherosclerotic Disease
Large elastic arteries and large and medium-sized
muscular arteries are the major targets of
atherosclerosis
the heart, brain, kidneys, and lower extremities
Myocardial infarction
cerebral infarction (stroke), aortic aneurysms, and
peripheral vascular disease (gangrene of the legs)
46. Atherosclerotic Stenosis
plaques can gradually occlude vessel lumina,
compromising blood flow and causing ischemic
injury --- Critical stenosis
In coronary circulations--- 70% decrease in luminal
cross-sectional area
mesenteric occlusion and bowel ischemia, sudden
cardiac death, chronic ischemic heart disease,
ischemic encephalopathy, and intermittent
claudication
47. Acute Plaque Change
Plaque erosion or rupture ---partial or complete
vascular thrombosis
Plaque changes fall into three general categories:
Rupture/fissuring, exposing highly thrombogenic plaque
constituents
Erosion/ulceration, exposing the thrombogenic
subendothelial basement membrane to blood
Hemorrhage into the atheroma, expanding its volume
48. a large number of now asymptomatic adults may be at risk
for a catastrophic coronary event.
Plaques rupture when they are unable to withstand
mechanical stresses generated by vascular shear forces
The events that trigger abrupt changes in plaques and
subsequent thrombosis are complex and include both
intrinsic factors (e.g., plaque structure and composition)
and extrinsic elements (e.g., blood pressure, platelet
reactivity, vessel spasm).
The composition of plaques is dynamic
Thus, plaques -- large areas of foam cells and lipid, fibrous
caps are thin or contain few smooth muscle cells or have
clusters of inflammatory cells--- more likely to rupture------
vulnerable plaques
50. Thrombosis.
partial or total thrombosis superimposed on a
disrupted plaque is a central factor in acute
coronary syndromes.
luminal obstruction by the thrombus is incomplete,
and may even wax and wane with time.
Mural thrombi in a coronary artery can also
embolize.
51. Vasoconstriction.
compromises lumen size, and, by increasing the local
mechanical forces, can potentiate plaque disruption.
stimulated by
(1) circulating adrenergic agonists
(2) locally released platelet contents
(3) endothelial cell dysfunction with impaired secretion of
NO
(4) mediators released from perivascular inflammatory cells
52. Altered Vessel Function
Vessel change Consequence
Plaque narrows lumen
Wall weakened
Thrombosis
Breaking loose of plaque
Loss of elasticity
Ischemia, turbulence
Aneurysms, vessel rupture
Narrowing, ischemia, embolization
Athero-embolization
Increase systolic blood pressure